Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Electrochemotherapy treatment saves cat with painful tumour
Pictured: Acai the cat.
The treatment was given by Gerry Poulton at NDSR.

Veterinary professionals at North Downs Specialist Referrals are 'delighted' after a cat with tongue cancer is doing well after receiving electrochemotherapy treatment.

Acai the cat is receiving treatment from oncology specialist Gerry Polton, oncology service director at North Downs Specialist Referrals. 

Gerry, who has described Acai's progress as 'extraordinary', commented on Acai's diagnosis:  “Acai is a lovely big cat who was diagnosed with a squamous cell carcinoma on the underside of his tongue. 

“This is a painful and destructive tumour and, normally, life expectancy for these cases is only about 50 days, with appropriate pain relief.”

With little to no treatment options for Acai's condition, the specialist decided that he was a strong candidate to receive electrochemotherapy treatment, and Acai began treatment in April 2020. 

Electrochemotherapy treatment combines a low dose of a chemotherapy drug and an electrical pulse, applied directly by an electrode. When this electrical pulse is applied, the cells form pores, allowing the drug to enter. 

The practice found that Acai was incredibly receptive to the treatment, with the tumour resolving visibly and the mass being no longer apparent after only three treatments.

After the first course of treatment, which involved six treatments, Acai remained in remission until February 2021, when he then received further electrochemotherapy.

Gerry commented on this process: “We performed two treatments two weeks apart but Acai lost his appetite after the second treatment, so no more were given.

“We expected that the tumour would begin to progress quite rapidly but remarkably he has responded so well and has got his appetite back. 

“It is now 18 months since the lump was first identified and the fact that he is happy and well at this point is extraordinary. 

“We’re delighted and want to share this success story to raise awareness of the treatment so that other cats can benefit from it”

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
Defra to host bluetongue webinar for vets

The Department for Environment, Food and Rural Affairs (Defra) will be hosting a webinar for veterinary professional on bluetongue on Thursday, 25 April 2024.

Topics covered will include the transmission cycle, pathology and pathogenesis, clinical signs (including signs seen in recent BTV-3 cases in the Netherlands), and control and prevention.

The session, which will take place from 6pm to 7.30pm, is part of Defra's 'Plan, Prevent and Protect' webinar series, which are hosted by policy officials, epidemiologists and veterinary professionals from Defra and the Animal and Plant Health Agency. The bluetongue session will also feature insights from experts from The Pirbright Institute.

Those attending will have the opportunity to ask questions. Places on the webinar can be booked online.